Shanghai Labway Clinical Laboratory Co Ltd (301060) — Capital Reinvestment Ratio
Shanghai Labway Clinical Laboratory Co Ltd (301060) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥135.78 Million) in capital expenditures (CN¥13.41 Million). See debt-free asset ratio of Shanghai Labway Clinical Laboratory Co L to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Labway Clinical Laboratory Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Shanghai Labway Clinical Laboratory Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check Shanghai Labway Clinical Laboratory Co L (301060) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see Shanghai Labway Clinical Laboratory Co L market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥268.85 Million | CN¥58.49 Million | ▼ -38.6% |
| 2024 | 0.35x | CN¥216.31 Million | CN¥76.62 Million | ▼ -51.4% |
| 2023 | 0.73x | CN¥546.99 Million | CN¥398.89 Million | ▼ -73.3% |
| 2022 | 2.73x | CN¥84.17 Million | CN¥230.08 Million | ▲ +413.9% |
| 2021 | 0.53x | CN¥223.51 Million | CN¥118.88 Million | ▲ +100.4% |
| 2020 | 0.27x | CN¥167.87 Million | CN¥44.55 Million | ▼ -52.6% |
| 2019 | 0.56x | CN¥70.60 Million | CN¥39.51 Million | ▲ +41.0% |
| 2018 | 0.40x | CN¥184.79 Million | CN¥73.34 Million | ▼ -89.6% |
| 2016 | 3.80x | CN¥27.14 Million | CN¥103.24 Million | ▲ +614.4% |
| 2015 | 0.53x | CN¥79.70 Million | CN¥42.45 Million | ▼ -94.6% |
| 2013 | 9.90x | CN¥1.63 Million | CN¥16.13 Million | — |